Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 24, 2003. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
The filing details two specific transactions involving the GlaxoSmithKline Employee Trust ("GSK Trust") and the SmithKline Beecham Employee Share Option Plan 1991:
- July 22, 2003: Abacus (GSK) Trustees Limited transferred 7,658 Ordinary Shares to plan participants.
- July 23, 2003: Abacus (GSK) Trustees Limited transferred 2,338 Ordinary Shares to plan participants.
Directors Dr J-P Garnier and Mr J D Coombe hold interests in the shares held by the GSK Trust in the same capacity as other employees or former employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Points
- Verify the total number of shares transferred from the GSK Trust to the Employee Share Option Plan (10,000 shares total across two dates).
- Confirm the specific roles of Dr J-P Garnier and Mr J D Coombe regarding their indirect interest in the trust shares.
- Note that this filing contains no financial performance data; refer to Form 20-F for comprehensive financial results.